Download FREE Report Sample
Download Free sampleThe canine arthritis treatment types include non-steroidal anti-inflammatory medications (NSAIDs), opioids and stem cell Canine Arthritis Treatment. Non-steroidal anti-inflammatory Canine Arthritis Treatment are used to control pain and inflammation associated with arthritis. They are most commonly used canine arthritis treatment drugs. NSAIDs are used to treat mild to moderate pain by reducing the production of prostaglandins, which is involved with inflammation and discomfort.?
Canine Arthritis Therapeutics Market contains market size and forecasts of Canine Arthritis Therapeutics in Global, including the following market information:
Global Canine Arthritis Therapeutics Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Canine Arthritis Therapeutics market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Non-Steroidal Anti-Inflammatory Drugs Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Canine Arthritis Therapeutics include Elanco (Eli Lilly and Company), Boehringer Ingelheim, Zoetis Inc, Vetoquinol S.A., Bayer AG, Aratana Therapeutics Inc, Norbrook Laboratories Limited, VetStem Biopharma and Dechra Pharmaceuticals Plc. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Canine Arthritis Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Canine Arthritis Therapeutics Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Canine Arthritis Therapeutics Market Segment Percentages, by Type, 2021 (%)
Non-Steroidal Anti-Inflammatory Drugs
Opioids
Stem Cell Therapy
Global Canine Arthritis Therapeutics Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Canine Arthritis Therapeutics Market Segment Percentages, by Application, 2021 (%)
Veterinary Hospitals and Clinics
Retail Pharmacies
Drug Stores
Global Canine Arthritis Therapeutics Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Canine Arthritis Therapeutics Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Canine Arthritis Therapeutics revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Canine Arthritis Therapeutics revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Elanco (Eli Lilly and Company)
Boehringer Ingelheim
Zoetis Inc
Vetoquinol S.A.
Bayer AG
Aratana Therapeutics Inc
Norbrook Laboratories Limited
VetStem Biopharma
Dechra Pharmaceuticals Plc
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy
Industry Market SizeSWOT AnalysisIndustry Major PlayersRevenue ForecastsHistorical and Forecast GrowthProfitability Analysis
